Atlas Trials

Minimum Effective Volume of 0.375% Bupivacaine in Interscalene Brachial Plexus Block

Clinical trial NCT01667315 · UNKNOWN

Trial details

NCT number
NCT01667315
Sponsor
Federal University of São Paulo
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Shoulder Surgery
Start date
2012-08-01
Primary completion
2013-01-01
Enrollment
33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.